$STRM
STREAMLINE HEALTH SOLUTIONS INC. Stock $strm

$strm Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222025383 Filed on September 08, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$5.992M	$5.935M	$6.046M
YoY Change	108.93%	101.12%	103.57%
Cost Of Revenue	$3.204M	$3.209M	$3.081M
YoY Change	122.81%	123.31%	93.77%
Gross Profit	$2.788M	$2.726M	$2.965M
YoY Change	94.97%	80.05%	113.31%
Gross Profit Margin	46.53%	45.93%	49.04%
Selling, General & Admin	$3.934M	$4.501M	$3.424M
YoY Change	56.42%	76.44%	100.23%
% of Gross Profit	141.1%	165.11%	115.48%
Research & Development	$1.461M	$1.310K	$1.502M
YoY Change	51.56%	-99.87%	51.72%
% of Gross Profit	52.4%	0.05%	50.66%
Depreciation & Amortization	$959.0K	$971.0K	$993.0K
YoY Change	57.21%	51.25%	48.21%
% of Gross Profit	34.4%	35.62%	33.49%
Operating Expenses	$5.395M	$5.813M	$4.926M
YoY Change	55.07%	64.77%	83.12%
Operating Profit	-$2.656M	-$3.087M	-$1.961M
YoY Change	29.62%	53.28%	50.85%
Interest Expense	$189.0K	-$132.0K	-$129.0K
YoY Change	-2200.0%	915.38%	1190.0%
% of Operating Profit
Other Income/Expense, Net	-$425.0K	$533.0K	$2.332M
YoY Change	5212.5%	3453.33%	23220.0%
Pretax Income	-$3.270M	-$2.776M	$96.00K
YoY Change	4260.0%	13.17%	-107.33%
Income Tax	$2.000K	$11.00K	$100.0K
% Of Pretax Income			104.17%
Net Earnings	-$3.272M	-$2.787M	-$30.00K
YoY Change	5353.33%	30.11%	-97.48%
Net Earnings / Revenue	-54.61%	-46.96%	-0.5%
Basic Earnings Per Share	-$0.07	-$0.06
Diluted Earnings Per Share	-$0.07	-$59.26K	-$641.50
COMMON SHARES
Basic Shares Outstanding	47.23M shares	47.03M shares
Diluted Shares Outstanding	47.41M shares	47.03M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.918M	$7.955M	$9.885M
YoY Change	-62.66%	-52.44%	310.17%
Cash & Equivalents	$5.918M	$7.955M	$9.885M
Short-Term Investments
Other Short-Term Assets	$945.0K	$423.0K	$568.0K
YoY Change	-2.48%	-70.65%	-68.62%
Inventory
Prepaid Expenses
Receivables	$3.545M	$4.660M	$3.823M
Other Receivables	$771.0K	$671.0K	$843.0K
Total Short-Term Assets	$11.18M	$13.71M	$15.12M
YoY Change	-43.19%	-36.57%	106.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$233.0K	$282.0K	$341.0K
YoY Change	-39.01%	-34.72%	-31.8%
Goodwill	$23.09M		$23.09M
YoY Change
Intangibles	$15.71M		$16.76M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.175M	$1.002M	$948.0K
YoY Change	16.8%	4.59%	6.52%
Total Long-Term Assets	$45.78M	$46.25M	$46.70M
YoY Change	152.11%	150.98%	150.25%
TOTAL ASSETS
Total Short-Term Assets	$11.18M	$13.71M	$15.12M
Total Long-Term Assets	$45.78M	$46.25M	$46.70M
Total Assets	$56.96M	$59.96M	$61.82M
YoY Change	50.55%	49.75%	137.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$669.0K	$1.013M	$778.0K
YoY Change	84.3%	316.87%	188.15%
Accrued Expenses	$2.436M	$2.843M	$2.007M
YoY Change	59.74%	127.08%	80.81%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$500.0K	$375.0K	$250.0K
YoY Change		-83.7%	-83.7%
Total Short-Term Liabilities	$14.67M	$15.01M	$13.50M
YoY Change	120.71%	64.23%	83.19%
LONG-TERM LIABILITIES
Long-Term Debt	$9.444M	$9.549M	$9.654M
YoY Change			1158.67%
Other Long-Term Liabilities	$116.0K	$3.965M	$4.616M
YoY Change	-60.27%	1045.95%
Total Long-Term Liabilities	$13.79M	$13.51M	$9.654M
YoY Change		3805.78%	1158.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.67M	$15.01M	$13.50M
Total Long-Term Liabilities	$13.79M	$13.51M	$9.654M
Total Liabilities	$28.46M	$28.52M	$27.77M
YoY Change	310.19%	200.75%	227.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$91.72M		-$85.66M
YoY Change
Common Stock	$120.2M		$119.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$28.51M	$31.44M	$34.04M
YoY Change
Total Liabilities & Shareholders Equity	$56.96M	$59.96M	$61.82M
YoY Change	50.55%	49.75%	137.93%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$3.272M	-$2.787M	-$30.00K
YoY Change	5353.33%	30.11%	-97.48%
Depreciation, Depletion And Amortization	$959.0K	$971.0K	$993.0K
YoY Change	57.21%	51.25%	48.21%
Cash From Operating Activities	-$1.681M	-$1.270M	$112.0K
YoY Change	42.1%	-1648.78%	-53.33%
INVESTING ACTIVITIES
Capital Expenditures	-$362.0K	-$519.0K	-$433.0K
YoY Change	9.37%	37.3%	49.31%
Acquisitions
YoY Change
Other Investing Activities	$0.00		-$116.0K
YoY Change	-100.0%
Cash From Investing Activities	-$362.0K	-$519.0K	-$549.0K
YoY Change	-177.19%	37.3%	89.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.000K	-141.0K	-87.00K
YoY Change	-103.61%	-100.96%	-84.74%
NET CHANGE
Cash From Operating Activities	-1.681M	-1.270M	112.0K
Cash From Investing Activities	-362.0K	-519.0K	-549.0K
Cash From Financing Activities	6.000K	-141.0K	-87.00K
Net Change In Cash	-2.037M	-1.930M	-524.0K
YoY Change	131.48%	-113.48%	-15.48%
FREE CASH FLOW
Cash From Operating Activities	-$1.681M	-$1.270M	$112.0K
Capital Expenditures	-$362.0K	-$519.0K	-$433.0K
Free Cash Flow	-$1.319M	-$751.0K	$545.0K
YoY Change	54.81%	-263.26%	2.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2022Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax		usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q3	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations		usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2022Q3	STRM	Forgiveness Of Ppp Loan And Accrued Interest ForgivenessOfPppLoanAndAccruedInterest		usd
	STRM	Forgiveness Of Ppp Loan And Accrued Interest ForgivenessOfPppLoanAndAccruedInterest		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001008586
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax		usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest		usd
	STRM	Change In Fair Value Of Acquisition Earnout Liability ChangeInFairValueOfAcquisitionEarnoutLiability		usd
	STRM	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts		usd
	STRM	Forgiveness Of Ppp Loan And Accrued Interest ForgivenessOfPppLoanAndAccruedInterest		usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare
CY2022Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic		usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic		usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare
CY2022Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted		usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted		usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2022Q3	STRM	Business Combination Executive Bonuses BusinessCombinationExecutiveBonuses		usd
CY2021Q3	STRM	Business Combination Executive Bonuses BusinessCombinationExecutiveBonuses		usd
	STRM	Business Combination Executive Bonuses BusinessCombinationExecutiveBonuses		usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-07-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-28132
	dei	Entity Registrant Name EntityRegistrantName	STREAMLINE HEALTH SOLUTIONS, INC.
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	31-1455414
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11800 Amber Park Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 125
	dei	Entity Address City Or Town EntityAddressCityOrTown	Alpharetta
	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30009
	dei	City Area Code CityAreaCode	(888)
	dei	Local Phone Number LocalPhoneNumber	997-8732
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
	dei	Trading Symbol TradingSymbol	STRM
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48786709	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5918000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9885000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3545000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3823000	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	771000	usd
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	843000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	945000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	568000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	11179000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	15119000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	106000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	123000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	127000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	218000	usd
CY2022Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5579000	usd
CY2022Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5555000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15707000	usd
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16763000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	23089000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	23089000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1175000	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	948000	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	45783000	usd
CY2022Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	46696000	usd
CY2022Q3	us-gaap	Assets Assets	56962000	usd
CY2022Q1	us-gaap	Assets Assets	61815000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	669000	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	778000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2436000	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1803000	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	500000	usd
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	250000	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6189000	usd
CY2022Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5794000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	138000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	204000	usd
CY2022Q3	us-gaap	Asset Acquisition Contingent Consideration Liability Current AssetAcquisitionContingentConsiderationLiabilityCurrent	4734000	usd
CY2022Q1	us-gaap	Asset Acquisition Contingent Consideration Liability Current AssetAcquisitionContingentConsiderationLiabilityCurrent	4672000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14666000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	13501000	usd
CY2022Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	9444000	usd
CY2022Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	9654000	usd
CY2022Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	155000	usd
CY2022Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	136000	usd
CY2022Q1	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	33000	usd
CY2022Q3	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	4074000	usd
CY2022Q1	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	4161000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	116000	usd
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	286000	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	13789000	usd
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14270000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	28455000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	27771000	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	488000	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	478000	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	119737000	usd
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	119225000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-91718000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85659000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	28507000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	34044000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56962000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61815000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5992000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2868000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11927000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5819000	usd
CY2022Q3	STRM	Cost Of Software Licenses CostOfSoftwareLicenses	92000	usd
CY2021Q3	STRM	Cost Of Software Licenses CostOfSoftwareLicenses	143000	usd
	STRM	Cost Of Software Licenses CostOfSoftwareLicenses	193000	usd
	STRM	Cost Of Software Licenses CostOfSoftwareLicenses	279000	usd
CY2022Q3	STRM	Cost Of Professional Services CostOfProfessionalServices	1034000	usd
CY2021Q3	STRM	Cost Of Professional Services CostOfProfessionalServices	261000	usd
	STRM	Cost Of Professional Services CostOfProfessionalServices	2160000	usd
	STRM	Cost Of Professional Services CostOfProfessionalServices	475000	usd
CY2022Q3	STRM	Cost Of Audit Services CostOfAuditServices	456000	usd
CY2021Q3	STRM	Cost Of Audit Services CostOfAuditServices	376000	usd
	STRM	Cost Of Audit Services CostOfAuditServices	895000	usd
	STRM	Cost Of Audit Services CostOfAuditServices	765000	usd
CY2022Q3	STRM	Cost Of Maintenance And Support CostOfMaintenanceAndSupport	90000	usd
CY2021Q3	STRM	Cost Of Maintenance And Support CostOfMaintenanceAndSupport	80000	usd
	STRM	Cost Of Maintenance And Support CostOfMaintenanceAndSupport	136000	usd
	STRM	Cost Of Maintenance And Support CostOfMaintenanceAndSupport	166000	usd
CY2022Q3	STRM	Cost Of Software As Service CostOfSoftwareAsService	1532000	usd
CY2021Q3	STRM	Cost Of Software As Service CostOfSoftwareAsService	578000	usd
	STRM	Cost Of Software As Service CostOfSoftwareAsService	3029000	usd
	STRM	Cost Of Software As Service CostOfSoftwareAsService	1188000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3934000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2515000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8435000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5068000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1461000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	964000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2773000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1941000	usd
CY2022Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	49000	usd
CY2021Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	336000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	139000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	777000	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	8648000	usd
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	5253000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	17760000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	10659000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2656000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2385000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5833000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4840000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	189000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	9000	usd
	us-gaap	Interest Expense InterestExpense	321000	usd
	us-gaap	Interest Expense InterestExpense	22000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-425000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	108000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6000	usd
CY2021Q3	STRM	Forgiveness Of Ppp Loan And Accrued Interest ForgivenessOfPppLoanAndAccruedInterest	2327000	usd
	STRM	Forgiveness Of Ppp Loan And Accrued Interest ForgivenessOfPppLoanAndAccruedInterest	2327000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3270000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-75000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6046000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2529000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3272000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-71000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6059000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2534000	usd
CY2021Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	11000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	332000	usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	11000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	332000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3272000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-60000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6059000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2202000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.07
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.06
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47231296	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41288709	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47129879	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39393333	shares
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.07
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.06
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47410949	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41737231	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47348455	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39960998	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	34044000	usd
CY2022Q2	STRM	Surrender Of Stockduring Period Value SurrenderOfStockduringPeriodValue	-141000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	326000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2787000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	31442000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	331000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3272000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	28507000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	17489000	usd
CY2021Q2	STRM	Surrender Of Stockduring Period Value SurrenderOfStockduringPeriodValue	-161000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	565000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16100000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-1293000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2142000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	30558000	usd
CY2021Q3	STRM	Surrender Of Stockduring Period Value SurrenderOfStockduringPeriodValue	-130000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	557000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-25000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-60000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	30900000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6059000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2202000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	332000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6059000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2534000	usd
	us-gaap	Depreciation Depreciation	27000	usd
	us-gaap	Depreciation Depreciation	37000	usd
	STRM	Amortization Of Capitalized Software Development Costs AmortizationOfCapitalizedSoftwareDevelopmentCosts	847000	usd
	STRM	Amortization Of Capitalized Software Development Costs AmortizationOfCapitalizedSoftwareDevelopmentCosts	984000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1056000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	231000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	229000	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	242000	usd
	STRM	Change In Fair Value Of Acquisition Earnout Liability ChangeInFairValueOfAcquisitionEarnoutLiability	25000	usd
	STRM	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	40000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	657000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1122000	usd
	STRM	Provision Benefit For Doubtful Accounts Receivable ProvisionBenefitForDoubtfulAccountsReceivable	-21000	usd
	STRM	Provision Benefit For Doubtful Accounts Receivable ProvisionBenefitForDoubtfulAccountsReceivable	1000	usd
	STRM	Forgiveness Of Ppp Loan And Accrued Interest ForgivenessOfPppLoanAndAccruedInterest	2327000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-329000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-243000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	742000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	622000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-109000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	91000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	364000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	352000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	414000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	645000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2951000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1537000	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	436000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	800000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	871000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	706000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-881000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	91000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	16100000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1318000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	141000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	291000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	38000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	6000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-5000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-135000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14448000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3967000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13438000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9885000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2409000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5918000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15847000	usd
	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_806_eus-gaap--BasisOfAccounting_zTfz1y6Zs8pb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">NOTE 1 — <span id="xdx_826_zLxzhrU6KqNh">BASIS OF PRESENTATION</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Streamline Health Solutions, Inc. and each of its wholly-owned subsidiaries, Streamline Health, LLC, Avelead Consulting, LLC, Streamline Consulting Solutions, LLC and Streamline Pay & Benefits, LLC, (collectively, unless the context requires otherwise, “we,” “us,” “our,” “Streamline,” or the “Company”), operate in one segment as a provider of healthcare information technology solutions and associated services. The Company provides these capabilities through the licensing of its Coding & CDI, eValuator coding analysis platform, RevID, and other workflow software applications and the use of such applications by software as a service (“SaaS”). The Company also provides audit and coding services to help customers optimize their internal clinical documentation and coding functions, as well as implementation and consulting services to complement its software solutions. The Company’s software and services enable hospitals and integrated healthcare delivery systems in the United States and Canada to capture, store, manage, route, retrieve and process patient clinical, financial and other healthcare provider information related to the patient revenue cycle.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared by us pursuant to the rules and regulations applicable to quarterly reports on Form 10-Q of the U.S. Securities and Exchange Commission (the “SEC”). Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures made are adequate to make the information not misleading. The condensed consolidated financial statements include the accounts of Streamline Health Solutions, Inc. and each of its wholly-owned subsidiaries. In the opinion of the Company’s management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the condensed consolidated financial statements have been included. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s most recent annual report on Form 10-K. Operating results for the three and six months ended July 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending January 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two or more operating segments may be aggregated into a single operating segment if they are considered to be similar. Operating segments are considered to be similar if they can be expected to have essentially the same economic characteristics and future prospects. Using the aggregation guidance, the Company determined that it has one operating segment due to the similar economic characteristics of the Company’s products, product development, distribution, regulatory environment and customer base as a provider of computer software-based solutions and services for acute-care healthcare providers. The Company has two reporting units for evaluation of intangible assets. These two reporting units are the legacy Streamline products and Avelead Consulting, LLC. Refer to “Note 3 – Business Combination and Divestiture”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All amounts in the condensed consolidated financial statements, notes and tables have been rounded to the nearest thousand dollars, except share and per share amounts, unless otherwise indicated. All references to a fiscal year refer to the fiscal year commencing February 1 in that calendar year and ending on January 31 of the following calendar year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zrkep5wT64ch" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zDR9jzh0niWa">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates and judgments, including those related to the recognition of revenue, share-based compensation, capitalization of software development costs, intangible assets, the allowance for doubtful accounts, contingent consideration, and income taxes. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1	STRM	Acquisition Earnout Liability Fair Value AcquisitionEarnoutLiabilityFairValue	8833000	usd
CY2022Q3	STRM	Acquisition Earnout Liability Fair Value AcquisitionEarnoutLiabilityFairValue	8808000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2534000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.07
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.06
CY2021Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	11000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5992000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2868000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11927000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5819000	usd
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	3690000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	21833000	usd
CY2022Q3	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	112000	usd
CY2022Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	125000	usd
CY2022Q3	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	134000	usd
CY2022Q1	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	93000	usd
CY2022Q3	STRM	Deferred Costs Amortization Expenses DeferredCostsAmortizationExpenses	21000	usd
CY2021Q3	STRM	Deferred Costs Amortization Expenses DeferredCostsAmortizationExpenses	28000	usd
	STRM	Deferred Costs Amortization Expenses DeferredCostsAmortizationExpenses	40000	usd
	STRM	Deferred Costs Amortization Expenses DeferredCostsAmortizationExpenses	67000	usd
CY2022Q3	STRM	Deferred Commission Costs Accumulated Amortization DeferredCommissionCostsAccumulatedAmortization	597000	usd
CY2022Q1	STRM	Deferred Commission Costs Accumulated Amortization DeferredCommissionCostsAccumulatedAmortization	408000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3272000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-71000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6059000	usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	332000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
CY2022Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-3272000	usd
CY2021Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-71000	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-6059000	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-2534000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.07
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.13
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.06
CY2021Q3	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	11000	usd
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	332000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3272000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-60000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6059000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2202000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47231296	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41288709	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47129879	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39393333	shares
CY2022Q3	STRM	Effect Of Dilutive Securities Stock Options Restricted Stocks EffectOfDilutiveSecuritiesStockOptionsRestrictedStocks	179653	shares
CY2021Q3	STRM	Effect Of Dilutive Securities Stock Options Restricted Stocks EffectOfDilutiveSecuritiesStockOptionsRestrictedStocks	448522	shares
	STRM	Effect Of Dilutive Securities Stock Options Restricted Stocks EffectOfDilutiveSecuritiesStockOptionsRestrictedStocks	218576	shares
	STRM	Effect Of Dilutive Securities Stock Options Restricted Stocks EffectOfDilutiveSecuritiesStockOptionsRestrictedStocks	567665	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47410949	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41737231	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47348455	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39960998	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	48000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	97000	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	49000	usd
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	336000	usd
	us-gaap	Professional Fees ProfessionalFees	139000	usd
	us-gaap	Professional Fees ProfessionalFees	427000	usd
	STRM	Business Combination Executive Bonuses BusinessCombinationExecutiveBonuses	350000	usd
CY2022Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	49000	usd
CY2021Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	336000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	139000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	777000	usd
CY2022Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	49000	usd
CY2021Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	336000	usd
	STRM	Forgiveness Of Ppp Loan And Accrued Interest ForgivenessOfPppLoanAndAccruedInterest	2327000	usd
CY2021Q3	STRM	Forgiveness Of Ppp Loan And Accrued Interest ForgivenessOfPppLoanAndAccruedInterest	2327000	usd
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	9904000	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	500000	usd
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	250000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9444000	usd
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9654000	usd
CY2022Q3	us-gaap	Asset Acquisition Contingent Consideration Liability Current AssetAcquisitionContingentConsiderationLiabilityCurrent	4734000	usd
CY2022Q3	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	4074000	usd
	STRM	Acquisition Earnout Liability Change In Valuation AcquisitionEarnoutLiabilityChangeInValuation	25000	usd
CY2021Q3	STRM	Acquired Finite Lived Intangible Assets Weighted Average Useful Life Description AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeDescription	Indefinite
	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	The Company and its subsidiaries are subject to U.S. federal income tax as well as income taxes in multiple state and local jurisdictions. The Company has concluded all U.S. federal tax matters for years through January 31, 2018. All material state and local income tax matters have been concluded for years through January 31, 2017. The Company is no longer subject to IRS examination for periods prior to the tax year ended January 31, 2018; however, carryforward losses that were generated prior to the tax year ended January 31, 2018 may still be adjusted by the IRS if they are used in a future period
CY2021Q3	us-gaap	Revenues Revenues	2868000	usd
CY2021Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	5039000	usd
	us-gaap	Revenues Revenues	5819000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	10521000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-71000	usd
CY2021Q3	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	-1082000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2534000	usd
	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	-3696000	usd
CY2022Q3	us-gaap	Sublease Income SubleaseIncome	48000	usd
	us-gaap	Sublease Income SubleaseIncome	96000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	127000	usd
CY2022Q3	STRM	Current Portion Of Operating Lease Obligation CurrentPortionOfOperatingLeaseObligation	138000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	106000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	35000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	141000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	138000	usd
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	65000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	2000000	shares
CY2022Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10000000	usd
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10000000	usd
CY2022Q3	STRM	Debt Instrument Financing Cost Payable DebtInstrumentFinancingCostPayable	45000	usd
CY2022Q1	STRM	Debt Instrument Financing Cost Payable DebtInstrumentFinancingCostPayable	21000	usd
CY2022Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	101000	usd
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	117000	usd
CY2022Q3	us-gaap	Long Term Debt LongTermDebt	9944000	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-8000	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-5000	usd
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-5000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-13000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-5000	usd
CY2022Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	46250000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2515	pure
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	318000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	315000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	2000000	shares
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	109906	shares
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	43000	usd
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	396.000	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	2000	usd
	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	4000	usd
CY2021Q3	STRM	Transition Service Cost TransitionServiceCost	30000	usd
	STRM	Transition Service Cost TransitionServiceCost	60000	usd
CY2021Q3	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	32000	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	64000	usd
CY2021Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	11000	usd
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	332000	usd

Files In Submission

Name	View Source	Status
0001493152-22-025383-index-headers.html	Edgar Link	pending
0001493152-22-025383-index.html	Edgar Link	pending
0001493152-22-025383.txt	Edgar Link	pending
0001493152-22-025383-xbrl.zip	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
strm-20220731.xsd	Edgar Link	pending
strm-20220731_pre.xml	Edgar Link	unprocessable
strm-20220731_lab.xml	Edgar Link	unprocessable
strm-20220731_cal.xml	Edgar Link	unprocessable
strm-20220731_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STRM
STREAMLINE HEALTH SOLUTIONS INC. Stock $strm

2022 Q3 Form 10-Q Financial Statement

#000149315222025383 Filed on September 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STRM STREAMLINE HEALTH SOLUTIONS INC. Stock $strm

2022 Q3 Form 10-Q Financial Statement

#000149315222025383 Filed on September 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STRM
STREAMLINE HEALTH SOLUTIONS INC. Stock $strm